VIROLOGY TESTING MARKET ANALYSIS

Virology Testing Market by Diagnostic Technique (Molecular Diagnostics Method [PCR based methods and NGS based methods], Immunoassay based Method, Mass Spectroscopy based Method, and Others), by Product Type (Instruments and Assay kits and Consumables), by End User (Hospitals, Diagnostic Centers, Blood Banks, and Others) and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

Key Development

In 2018, Bruker Corporation acquired Hain Lifescience GmbH, a molecular diagnostics company. This acquisiotn will expand the Bruker Corporation’s molecular diagnostic product portfolio.
In 2018, QIAGEN N.V. and NeuMoDx Molecular, Inc. entered into strategic partnership to commercialize two new fully integrated systems for automation of PCR (polymerase chain reaction) testing. These next-generation systems are specifically designed to help clinical molecular diagnostic laboratories process.
In 2017, Quidel Corporation entered into definitive agreement to acquire Triage MeterPro cardiovascular (CV) and toxicology assets and the B-type Naturietic Peptide (BNP) assay business from Alere Inc.
In 2015, Eurofins Scientific acquired Diatherix Laboratories, Inc. which offers clinical laboratories services on a multiplexing platform for the detection of infectious diseases.